GSK Hires First Female CEO of a Global Pharma Co - What Employees Think

September 20, 2016

GSK made history when it appointed Emma Walmsley CEO of a global pharmaceutical company. She will succeed Andrew Witty who served as CEO for the last 8 years.

Ms Walmsley has presided over a rapid expansion of GSK's consumer health unit after a 17 year stint at L'Oreal. Her appointment has drawn mixed comments. While acknowledging her success in consumer health, some wonder if she is the right choice to invigorate GSK's R&D efforts. GSK's anemic R&D output in recent years has left the global giant with an unexciting pipeline.

Cafepharma users have begun to weigh in on the choice. Some applaud the choice (perhaps a little backhandedly), 

Great hire for a future company split! GSK Consumer will be a great company once the split happens.
The future is with consumer, makes sense why they choose her.
See thread here

Others are openly derisive of her consumer health experience - see this thread.

No doubt, she will receive plenty of valuable feedback from the field.

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.